Source: Annual Congress 2008 - Issues in the management of COPD in the community
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Gwavava (Sheffield, United Kingdom). Coronary artery disease risk score calculation and evaluation of statin and antithrombotic drug use among patients admitted with an acute exacarbation of COPD. Eur Respir J 2008; 32: Suppl. 52, 3514

Member's Comments

No comment yet.

Related content which might interest you: Current symptom-based risk scores for stable coronary artery disease evaluation are not applicable in COPD patients Source: ERJ Open Res, 6 (4) 00492-2020; 10.1183/23120541.00492-2020 Year: 2020 Lipid profile in COPD patients with coronary artery disease comorbidity Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 The risk of development of coronary artery disease and 10 years Systemic Coronary Risk Evaluation at patients with COPD Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Comparison of cardiopulmonary exercise test in COPD patients with and without coronary artery disease Source: Annual Congress 2013 –The best posters in exercise testing and physical inactivity Year: 2013 Impact of two 5-year anticoagulant strategies on survival and echocardiographic parameters in the patients with chronic thromboembolic pulmonary hypertension (CTEPH) who did not undergo pulmonary endarterectomy Source: Annual Congress 2004 - Pulmonary embolism Year: 2004 Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Prevalence of cardiovascular risk factors and coronary artery disease in patients with COPD Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Comorbit coronary artery disease is related to worse outcomes in patients hospitalised for COPD exacerbation Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Prevalence and underdiagnosis of COPD in patients with ischemic heart disease demonstrated by coronary angiography. Prognostic implications Source: International Congress 2015 – COPD: notable points Year: 2015 Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients Source: Eur Respir J, 52 (5) 1800248; 10.1183/13993003.00248-2018 Year: 2018 Visual estimate of coronary artery calcium predicts cardiovascular disease in COPD Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities Year: 2016 Cardiointervalography in COPD patients with concomitant coronary heart disease Source: Eur Respir J 2005; 26: Suppl. 49, 509s Year: 2005 Role of a clinical prediction score in a chronic thromboembolic pulmonary hypertension rule-out strategy Source: Eur Respir J, 51 (4) 1702576; 10.1183/13993003.02576-2017 Year: 2018 Predictors of coronary heart disease in patients with COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Pulmonary angioplasty vs exclusive medical treatment in inoperable chronic thromboembolic hypertension–initial outcomes from a pulmonary hypertension centre Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 The beta-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD treatment Year: 2013 Beta-blocker use and risk of acute exacerbations of COPD following first-time myocardial infarction. A Danish nationwide cohort study. Source: International Congress 2019 – More and more COPD Year: 2019 Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease Source: Eur Respir J 2014; 44: 1635-1645 Year: 2014 Supervised exercise training in patients with chronic thromboembolic pulmonary hypertension (CTEPH) as early follow-up treatment after pulmonary endarterectomy (PEA) – a prospective cohort study Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Coronary artery calcification in COPD is associated with adverse functional assessments and mortality Source: Annual Congress 2012 - COPD is not a pulmonary disease alone Year: 2012